One small trial of colchicine in HFrEF patients found that although colchicine caused a reduction in inflammatory markers (CRP and IL-6) it did not cause any improvements in exercise capacity, symptoms or reductions in HF hospitalisation or mortality (109). The gene discussed is CRP; the disease is hydrops fetalis.